Fabrício Dos Santos Veloso

Learn More
OBJECTIVE To evaluate topiramate as monotherapy in adults and children with recently diagnosed, localization-related epilepsy, comparing two dosages of topiramate in a multicenter, randomized, double-blind study. METHODS Adults and children (>/=3 years of age) were eligible if the maximum interval since epilepsy diagnosis was 3 years and patients had one(More)
Anxiety sensitivity (AS) plays an important role in the cognitive, affective and behavioral profiles of patients with chronic pain related to musculoskeletal injury. However, investigators have not considered whether these findings extend to patients with other classes of chronic pain. The primary purpose of this investigation was to address this issue in(More)
Remacemide hydrochloride is a low-affinity, non-competitive NMDA receptor channel blocker under investigation for the treatment of epilepsy. This double-blind, placebo-controlled, multicentre study assessed the safety and efficacy of adjunctive remacemide hydrochloride or placebo, in adult patients with refractory epilepsy who were already taking up to(More)
The objective of the present investigation was to clarify the role that anxiety sensitivity (AS) and other related constructs play in headache medication use in patients with recurring headaches. A total of 108 patients (88% female) with chronic recurring headaches (mean duration = 205.6 months) provided complete responses to a self-report inventory(More)
  • J Carvalho, N Castro, L Chikovani, T Djobava, J Dodd, S Mcgrath +3 others
  • 2007
The ATLAS experiment sensitivity to top quark flavour changing neutral current (FCNC) decays was studied at LHC using t ¯ t events. While one of the top quarks is expected to follow the dominant Standard Model decay t → bW , the other decays through a FCNC channel, i.e. t → Zu(c), t → γu(c) or t → gu(c). Different types of analyses, applied to each FCNC(More)
BACKGROUND AND OBJECTIVES Functional inability of the affected limb is often added to alodynia and hyperalgesia in Complex Regional Pain Syndrome (CRPS) type I. Two CRPS cases are reported in which botulinum toxin A as coadjuvant drug has contributed to motor and functional recovery of the affected limb. CASE REPORTS Two CRPS type I patients were(More)
  • 1